机译:染色质修饰酶作为重编程调节剂
Stem Cell Transplantation Program,Division of Pediatric Hematology and Oncology,Manton Center for Orphan Disease Research,Children's Hospital Boston and Dana Farber Cancer Intitute,Boston,Massachusetts,02115,USA,Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,Boston,Massachusetts,02115,USA,Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Stem Cell Program,Children's Hospital Boston,Boston,Massachusetts,02115,USA;
German Cancer Research Center,Heidelberg,69120,Germany;
Stem Cell Transplantation Program,Division of Pediatric Hematology and Oncology,Manton Center for Orphan Disease Research,Children's Hospital Boston and Dana Farber Cancer Intitute,Boston,Massachusetts,02115,USA,Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,Boston,Massachusetts,02115,USA,Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Stem Cell Program,Children's Hospital Boston,Boston,Massachusetts,02115,USA;
Division of Hematology/Oncology,Children's Hospital,Harvard Medical School,Boston,Massachusetts,02115,USA,Department of Pediatric Oncology,Harvard Medical School,Boston,Massachusetts,02115,USA;
Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Division of Hematology/Oncology,Children's Hospital,Harvard Medical School,Boston,Massachusetts,02115,USA,Department of Pediatric Oncology,Harvard Medical School,Boston,Massachusetts,02115,USA;
Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Division of Hematology/Oncology,Children's Hospital,Harvard Medical School,Boston,Massachusetts,02115,USA,Department of Pediatric Oncology,Harvard Medical School,Boston,Massachusetts,02115,USA;
Stem Cell Transplantation Program,Division of Pediatric Hematology and Oncology,Manton Center for Orphan Disease Research,Children's Hospital Boston and Dana Farber Cancer Intitute,Boston,Massachusetts,02115,USA,Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,Boston,Massachusetts,02115,USA,Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Stem Cell Program,Children's Hospital Boston,Boston,Massachusetts,02115,USA;
Department of Molecular Biology and Genetics,Bilkent University,Ankara,06800,Turkey;
Stem Cell Transplantation Program,Division of Pediatric Hematology and Oncology,Manton Center for Orphan Disease Research,Children's Hospital Boston and Dana Farber Cancer Intitute,Boston,Massachusetts,02115,USA,Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,Boston,Massachusetts,02115,USA,Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Stem Cell Program,Children's Hospital Boston,Boston,Massachusetts,02115,USA;
Department of Biology,Massachusetts Institute of Technology,Cambridge,Massachusetts,02142,USA,Whitehead Institute for Bionedical Research,Cambridge,Massachusetts,02142,USA;
Department of Biology,Massachusetts Institute of Technology,Cambridge,Massachusetts,02142,USA,The Broad Institute of Harvard and Massachusetts Institute of Technology,Cambridge,Massachusetts,02142,USA,Department of Systems Biology,Harvard Medical School,Boston,Massachusetts,02115,USA;
Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Division of Hematology/Oncology,Children's Hospital,Harvard Medical School,Boston,Massachusetts,02115,USA,Department of Pediatric Oncology,Harvard Medical School,Boston,Massachusetts,02115,USA;
Stem Cell Transplantation Program,Division of Pediatric Hematology and Oncology,Manton Center for Orphan Disease Research,Children's Hospital Boston and Dana Farber Cancer Intitute,Boston,Massachusetts,02115,USA,Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,Boston,Massachusetts,02115,USA,Harvard Stem Cell Institute,Cambridge,Massachusetts,02138,USA,Stem Cell Program,Children's Hospital Boston,Boston,Massachusetts,02115,USA,Division of Hematology/Oncology,Children's Hospital,Harvard Medical School,Boston,Massachusetts,02115,USA,Division of Hematology,Brigham and Women's Hospital,Boston,Massachusetts,02115,USA,Howard Hughes Medical Institute,Chevy Chase,Maryland,20815,USA;
机译:染色质修饰酶作为重编程调节剂
机译:染色质修饰酶调节剂的特定组合可显着减弱胶质母细胞瘤细胞的增殖和活力,同时对正常成人干细胞的生长影响最小
机译:染色质修饰剂用于中风的表观遗传重编程和内源性神经干细胞介导的修复
机译:水凝胶的硬度通过间充质到上皮的转变和严厉性标志物调节细胞的重编程效率
机译:2-氧戊二酸酯和铁(II)依赖性加氧酶超家族的染色质修饰酶。
机译:染色质调节剂用于表观遗传重编程和内源神经干细胞介导的中风修复
机译:染色质修饰酶作为重编程调节剂